Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients
Top Cited Papers
- 20 October 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 120 (16), 1598-1605
- https://doi.org/10.1161/circulationaha.108.830299
Abstract
Background— Nonadherence to antihypertensive treatment is a common problem in cardiovascular prevention and may influence prognosis. We explored predictors of adherence to antihypertensive treatment and the association of adherence with acute cardiovascular events. Methods and Results— Using data obtained from 400 Italian primary care physicians providing information to the Health Search/Thales Database, we selected 18 806 newly diagnosed hypertensive patients ≥35 years of age during the years 2000 to 2001. Subjects included were newly treated for hypertension and initially free of cardiovascular diseases. Patient adherence was subdivided a priori into 3 categories—high (proportion of days covered, ≥80%), intermediate (proportion of days covered, 40% to 79%), and low (proportion of days covered, ≤40%)—and compared with the long-term occurrence of acute cardiovascular events through the use of multivariable models adjusted for demographic factors, comorbidities, and concomitant drug use. At baseline (ie, 6 months after index diagnosis), 8.1%, 40.5%, and 51.4% of patients were classified as having high, intermediate, and low adherence levels, respectively. Multiple drug treatment (odds ratio, 1.62; 95% CI, 1.43 to 1.83), dyslipidemia (odds ratio, 1.52; 95% CI, 1.24 to 1.87), diabetes mellitus (odds ratio, 1.40; 95% CI, 1.15 to 1.71), obesity (odds ratio, 1.50; 95% CI, 1.26 to 1.78), and antihypertensive combination therapy (odds ratio, 1.29; 95% CI, 1.15 to 1.45) were significantly ( P P =0.032). Conclusions— The long-term reduction of acute cardiovascular events associated with high adherence to antihypertensive treatment underscores its importance in assessments of the beneficial effects of evidence-based therapies in the population. An effort focused on early antihypertensive treatment initiation and adherence is likely to provide major benefits.This publication has 39 references indexed in Scilit:
- Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trialsBMJ, 2008
- Screening of Older Community‐Dwelling People at Risk for Death and Hospitalization: The Assistenza Socio‐Sanitaria in Italia ProjectJournal of the American Geriatrics Society, 2007
- The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and strokeCurrent Medical Research and Opinion, 2007
- Adherence to antihypertensive drug treatment and blood pressure control: a real practice analysis in ItalyJournal of Human Hypertension, 2007
- Rates and determinants of reinitiating antihypertensive therapy after prolonged stoppage: a population-based studyJournal of Hypertension, 2007
- Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based studyJournal of Human Hypertension, 2005
- Trends in the Sensitivity, Positive Predictive Value, False-Positive Rate, and Comparability Ratio of Hospital Discharge Diagnosis Codes for Acute Myocardial Infarction in Four US Communities, 1987-2000American Journal of Epidemiology, 2004
- Secondary Prevention of Stroke in ItalyStroke, 2003
- Selected major risk factors and global and regional burden of diseaseThe Lancet, 2002
- The Effect of Treatment on Mortality in Mild HypertensionThe New England Journal of Medicine, 1982